|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.23 USD | -1.92% |
|
-1.95% | -6.17% |
| Capitalization | 12.27B 10.56B 9.65B 9.21B 16.88B 1,177B 17.16B 116B 44.81B 559B 46.04B 45.05B 1,947B | P/E ratio 2026 * |
-20.8x | P/E ratio 2027 * | -62.7x |
|---|---|---|---|---|---|
| Enterprise value | 12.05B 10.37B 9.48B 9.04B 16.58B 1,156B 16.85B 114B 44B 549B 45.21B 44.24B 1,912B | EV / Sales 2026 * |
13.5x | EV / Sales 2027 * | 8x |
| Free-Float |
99.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | -1.92% | ||
| 1 week | -1.95% | ||
| Current month | -0.71% | ||
| 1 month | -3.37% | ||
| 3 months | -7.90% | ||
| 6 months | +3.75% | ||
| Current year | -6.17% |
| 1 week | 73.32 |  | 79.19 |
| 1 month | 71.18 | | 79.19 |
| Current year | 68.9 | | 86.74 |
| 1 year | 32 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 19.59 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 2012-06-30 |
Brett Monia
CEO | Chief Executive Officer | 64 | 2019-12-31 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 2000-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
B. Parshall
BRD | Director/Board Member | 71 | 2000-08-31 |
Joseph Wender
BRD | Director/Board Member | 81 | 1993-12-31 |
Joseph Klein
BRD | Director/Board Member | 64 | 2005-12-12 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | -1.95% | +125.01% | +104.83% | 12.27B | |
| -1.01% | -2.82% | -17.13% | -19.68% | 41.67B | |
| -3.73% | -6.04% | +29.90% | +22.07% | 32.6B | |
| -2.55% | +2.71% | +269.32% | +448.83% | 30.97B | |
| -0.91% | -5.37% | +20.43% | -11.67% | 28.23B | |
| -3.23% | -4.84% | +27.92% | +22.28% | 26.41B | |
| -2.03% | +0.77% | - | - | 14.94B | |
| +6.21% | -2.39% | +170.16% | +4,385.95% | 14.13B | |
| -0.20% | -0.10% | +6.70% | -2.02% | 12.12B | |
| -0.93% | -2.06% | +40.10% | +96.92% | 11.86B | |
| Average | -1.03% | -1.86% | +74.71% | +560.84% | 22.52B | |
| Weighted average by Cap. | -1.48% | -2.17% | +68.54% | +373.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 890M 766M 701M 668M 1.23B 85.43B 1.25B 8.4B 3.25B 40.55B 3.34B 3.27B 141B | 1.48B 1.27B 1.16B 1.11B 2.03B 142B 2.07B 13.94B 5.39B 67.26B 5.54B 5.42B 234B |
| Net income | -594M -511M -467M -446M -817M -56.96B -831M -5.6B -2.17B -27.04B -2.23B -2.18B -94.21B | -199M -171M -156M -149M -273M -19.05B -278M -1.87B -725M -9.04B -745M -729M -31.5B |
| Net Debt | -220M -190M -173M -165M -303M -21.14B -308M -2.08B -805M -10.03B -827M -809M -34.96B | -460M -396M -362M -345M -633M -44.13B -643M -4.34B -1.68B -20.95B -1.73B -1.69B -72.99B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-15 | 74.23 $ | -1.92% | 2,119,183 |
| 26-05-14 | 75.68 $ | -2.47% | 1,798,305 |
| 26-05-13 | 77.60 $ | +2.33% | 1,360,373 |
| 26-05-12 | 75.83 $ | +0.60% | 1,408,887 |
| 26-05-11 | 75.38 $ | -0.44% | 1,533,667 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition